VIVIBABA INC has a total of 11 patent applications. It increased the IP activity by 75.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are HOOKIPA BIOTECH GMBH, SILLAJEN INC and TURNSTONE LP.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Wen Jing | 8 |
#2 | Pang Shen | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019108804A1 | Compositions and methods for drug delivery | |
WO2018148507A1 | Compositions and methods for recombinant nerve growth factor | |
WO2018126198A1 | Rnai therapies for cerebral ischemia |